SCHEMBL115877

SCHEMBL115877

CCO[SiH](CCc1ccccc1)OCC

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.41
ALDH1A1 P00352 2/20 0.39
HPGD P15428 1/20 0.39
ALOX15 P16050 1/20 0.39
ALOX12 P18054 1/20 0.39
CASP1 P29466 1/20 0.39
HSD17B10 Q99714 1/20 0.39
TAAR1 Q96RJ0 3/20 0.39
ATM Q13315 1/20 0.39
AOC3 Q16853 2/20 0.38
CHRM2 P08172 1/20 0.38
HTR1A P08908 1/20 0.38
ADRA2A P08913 1/20 0.38
CHRM1 P11229 1/20 0.38
DRD1 P21728 1/20 0.38
SLC6A2 P23975 1/20 0.38
SLC6A4 P31645 1/20 0.38
ADRA1A P35348 1/20 0.38
OPRM1 P35372 1/20 0.38
DRD3 P35462 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL707896 0.88 CHRM2 (0.44) AOC3CHRM2HTR1AADRA2ACHRM1
SCHEMBL703456 0.86 L3MBTL1 (0.44) CHRM2HTR1AADRA2ACHRM1DRD1
SCHEMBL28399190 0.85 SIGMAR1 (0.46) CHRM2HTR1AADRA2ACHRM1DRD1
SCHEMBL19470852 0.85 SIGMAR1 (0.46) CHRM2HTR1AADRA2ACHRM1DRD1
SCHEMBL19470831 0.85 SIGMAR1 (0.46) CHRM2HTR1AADRA2ACHRM1DRD1
SCHEMBL19470882 0.85 SIGMAR1 (0.46) CHRM2HTR1AADRA2ACHRM1DRD1
SCHEMBL19470828 0.85 SIGMAR1 (0.46) CHRM2HTR1AADRA2ACHRM1DRD1
SCHEMBL19470867 0.85 SIGMAR1 (0.46) CHRM2HTR1AADRA2ACHRM1DRD1
SCHEMBL20483791 0.85 SIGMAR1 (0.46) CHRM2HTR1AADRA2ACHRM1DRD1
SCHEMBL706073 0.84 IDO1 (0.38) TP53ALDH1A1HPGDALOX15ALOX12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 708 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025078379-A1 EASY TO CLEAN COATINGS WITH LOW FINGERPRINT VISIBILITY OPTITUNE OY (FI) 2025-04-17 WO claimed
EP-3986366-B1 COMPOSITION COMPRISING AT LEAST ONE ALKOXYSILANE, AT LEAST ONE NON-AMINO SILICONE AND WATER, THE ALKOXYSILANE/NON-AMINO SILICONE MASS RATIO RANGING FROM 95/5 TO 5/95 OREAL (FR) 2024-09-11 EP claimed
CN-114007576-B Anhydrous composition comprising at least one aminosilicone, at least one alkoxysilane and at least one colorant 莱雅公司 2023-12-01 CN claimed
US-20220331228-A1 ANHYDROUS COMPOSITION COMPRISING AT LEAST ONE AMINO SILICONE, AT LEAST ONE ALKOXYSILANE AND AT LEAST ONE COLORING AGENT L'OREAL (FR) 2022-10-20 US claimed
EP-3986366-A1 COMPOSITION COMPRISING AT LEAST ONE ALKOXYSILANE, AT LEAST ONE NON-AMINO SILICONE AND WATER, THE ALKOXYSILANE/NON-AMINO SILICONE MASS RATIO RANGING FROM 95/5 TO 5/95 L'OREAL (FR) 2022-04-27 EP claimed
EP-3986361-A1 ANHYDROUS COMPOSITION COMPRISING AT LEAST ONE AMINO SILICONE, AT LEAST ONE ALKOXYSILANE AND AT LEAST ONE COLORING AGENT L'OREAL (FR) 2022-04-27 EP claimed
CN-114007576-A Anhydrous composition comprising at least one aminosilicone, at least one alkoxysilane and at least one colorant 莱雅公司 2022-02-01 CN claimed
WO-2021214053-A1 PROCESS FOR DENSIFYING KERATIN FIBERS, BASED ON SILICONE, AN ALKOXYSILANE AND A COLORING AGENT L'OREAL (FR) 2021-10-28 WO claimed
US-10927219-B2 Crosslinked silsesquioxane random copolymers absorbing both UVA and UVB and method for preparing the same NANO AND MICRO TECHNOLOGIES CO., LTD. (KR) 2021-02-23 US claimed
WO-2020260273-A1 COMPOSITION COMPRISING AT LEAST ONE ALKOXYSILANE, AT LEAST ONE NON-AMINO SILICONE AND WATER, THE ALKOXYSILANE/NON-AMINO SILICONE MASS RATIO RANGING FROM 95/5 TO 5/95 L'OREAL (FR) 2020-12-30 WO claimed
CN-1374989-A Process for producing chemically treated fillers PPG IND OHIO INC (US) 2002-10-16 CN claimed
CN-1374988-A Process for producing chemically modified fillers PPG IND OHIO INC (US) 2002-10-16 CN claimed
EP-1212380-A1 CHEMICALLY MODIFIED SILICA FILLERS, PROCESS FOR PRODUCING, AND SILICONE COMPOSITIONS CONTAINING SAME DOW CORNING CORPORATION (US) 2002-06-12 EP claimed
EP-1208165-A1 PROCESS FOR PRODUCING CHEMICALLY MODIFIED FILLERS PPG Industries Ohio, Inc. (US) 2002-05-29 EP claimed
EP-1208164-A1 PROCESS FOR PRODUCING CHEMICALLY TREATED FILLERS PPG Industries Ohio Inc. (US) 2002-05-29 EP claimed
US-6384125-B1 CONTACTING ACIDIC AQUEOUS SUSPENSION OF PRECIPITATED OR COLLOIDAL SILICA WITH COMBINATION OF FUNCTIONALIZING COUPLING AGENT AND ORGANOMETALLIC HYDROPHOBING COMPOUND, NEUTRALIZING TO INCREASE PH, RECOVERING MODIFIED FILLER DOW CORNING CORPORATION 2002-05-07 US claimed
WO-2001021715-A1 PROCESS FOR PRODUCING CHEMICALLY MODIFIED FILLERS PPG INDUSTRIES OHIO, INC. (US) 2001-03-29 WO claimed
WO-2001014480-A1 CHEMICALLY MODIFIED SILICA FILLERS, PROCESS FOR PRODUCING, AND SILICONE COMPOSITIONS CONTAINING SAME DOW CORNING CORPORATION (US) 2001-03-01 WO claimed
WO-2001012733-A1 PROCESS FOR PRODUCING CHEMICALLY TREATED FILLERS PPG INDUSTRIES OHIO, INC. (US) 2001-02-22 WO claimed
EP-0126186-B1 ELASTIC MOULDING COMPOSITION, METHOD FOR ITS PREPARATION AND MOULDING, AND ITS USE Degussa Aktiengesellschaft (DE) 1988-04-06 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10927219-B2 Crosslinked silsesquioxane random copolymers absorbing both UVA and UVB and method for preparing the same XRCC5, ERCC5, XRCC6 TP53 1465/4885ALDH1A1 2141/4885HPGD 2371/4885
US-20220331228-A1 ANHYDROUS COMPOSITION COMPRISING AT LEAST ONE AMINO SILICONE, AT LEAST ONE ALKOXYSILANE AND AT LEAST ONE COLORING AGENT KRT18, SHH, VIM TP53 978/4885ALDH1A1 1160/4885HPGD 2443/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.